Grown Rogue International (GRUSF) EPS (Basic) (QoQ) (2009 - 2026)
Grown Rogue International (GRUSF) EPS (Basic) (QoQ) (2009 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - |
| 10 | Grown Rogue International | 110.47 Mn | 98.93 Mn | 5.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1,385.98% |
| Mar 31, 2026 | 100.00% |
| Dec 31, 2025 | -346.68% |
| Sep 30, 2024 | 90.74% |
| Oct 31, 2023 | -849.72% |
| Jul 31, 2023 | -50.30% |
| Apr 30, 2023 | -56.13% |
| Jul 31, 2021 | 96.49% |
| Apr 30, 2021 | 4.38% |
| Jan 31, 2021 | -3,525.97% |
| Oct 31, 2020 | 103.82% |
| Jul 31, 2020 | 46.17% |
| Apr 30, 2020 | 36.20% |
| Jan 31, 2020 | 24.66% |
| Oct 31, 2019 | -178.52% |
| Jul 31, 2019 | 53.92% |
| Apr 30, 2019 | 70.70% |
| Jan 31, 2019 | -4.15% |
| Oct 31, 2018 | 80.59% |
| Aug 31, 2018 | 29.28% |